Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

licencing

Janssen adds Astellas JAK inhibitor to its immunology portfolio

Licenses oral rheumatoid arthritis and psoriasis candidate ASP015K

EC pricing and reimbursement efficiency plans

The European Commission (EC) is working to help medicines reach the market quicker by streamlining the pricing and reimbursement process

- PMLiVE

AZ share buyback suspension prompts M&A speculation

Analysts query new CEO Pascal Soriot’s intention to preserve cash reserves

- PMLiVE

AZ launches science blog LabTalk

Hopes new blog will build relationships with potential collaborators

Novartis drug effective in hard-to-treat psoriasis

Secukinumab to commence phase III trials

- PMLiVE

Valeant appoints Howard Schiller to the board

He joins at a time of expansion for the Canadian pharma company

- PMLiVE

Europe developing roadmap for mHealth use and acceptance

EU's MovingLife project is currently consulting on mHealth needs and requirements

- PMLiVE

AstraZeneca drops Palatin’s obesity drug after trial subject suffers allergic reaction

But collaboration with the US biotech remains in place

Valeant offers $2.6bn to buy dermatology firm Medicis

Possible further addition to long list of Canadian pharma firm’s acquisitions

- PMLiVE

COPD-asthma cases set to grow in Europe as people live longer

Study also highlights the respiratory burden the elderly will face

AstraZeneca and BGT shelve experimental sepsis drug

Decision follows CytoFab’s poor mid-stage clinical trial results

- PMLiVE

Interview: Ken Jones, Astellas Pharma Europe

The president and CEO of Astellas Pharma Europe talks to Liz Wells about beating the economic downturn and the experience of working for a Japanese company

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links